PA
SVM

PharVision Advisers’s Silvercorp Metals SVM Stock Holding History

PharVision Advisers’s Portfolio SVM Stock Details SVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,925
Closed -$200K – 576
2025
Q4 		$200K Buy
+23,925
New +$174K 0.1% 561

Other funds holding SVM

HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PharVision Advisers's SVM Position: Q1 2026 in Review

PharVision Advisers sold out of Silvercorp Metals (SVM) in Q1 2026, closing a stake of 23,925 shares — an estimated $200K sold.

PharVision Advisers first reported a position in SVM in Q4 2025 and held it in 1 quarter. The position peaked at $200K in Q4 2025. 195 funds tracked by Wall St. Rank hold SVM as of Q1 2026.

  • PharVision Advisers reported no remaining Silvercorp Metals position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 23,925 Silvercorp Metals shares in Q1 2026, an estimated $200K.
  • PharVision Advisers first reported a position in Silvercorp Metals in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Silvercorp Metals position peaked at $200K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Silvercorp Metals as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.